266 related articles for article (PubMed ID: 24285687)
21. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
22. Hydrogen Activates ATP-Binding Cassette Transporter A1-Dependent Efflux Ex Vivo and Improves High-Density Lipoprotein Function in Patients With Hypercholesterolemia: A Double-Blinded, Randomized, and Placebo-Controlled Trial.
Song G; Lin Q; Zhao H; Liu M; Ye F; Sun Y; Yu Y; Guo S; Jiao P; Wu Y; Ding G; Xiao Q; Qin S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2724-33. PubMed ID: 25978109
[TBL] [Abstract][Full Text] [Related]
23. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
[TBL] [Abstract][Full Text] [Related]
24. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
[TBL] [Abstract][Full Text] [Related]
25. Dose-dependent reductions in plasma ceramides after anthocyanin supplementation are associated with improvements in plasma lipids and cholesterol efflux capacity in dyslipidemia: A randomized controlled trial.
Zhao Y; Xu H; Tian Z; Wang X; Xu L; Li K; Gao X; Fan D; Ma X; Ling W; Yang Y
Clin Nutr; 2021 Apr; 40(4):1871-1878. PubMed ID: 33131908
[TBL] [Abstract][Full Text] [Related]
26. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
27. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
[TBL] [Abstract][Full Text] [Related]
28. Atorvastatin and fenofibrate combination induces the predominance of the large HDL subclasses and increased apo AI fractional catabolic rates in New Zealand white rabbits with exogenous hypercholesterolemia.
Flores-Castillo C; Zamora-Pérez JÁ; Carreón-Torres E; Arzola-Paniagua A; Aguilar-Salinas C; López-Olmos V; Fragoso JM; Luna-Luna M; Rodríguez-Pérez JM; Franco M; Vargas-Alarcón G; Pérez-Méndez Ó
Fundam Clin Pharmacol; 2015 Aug; 29(4):362-70. PubMed ID: 25982284
[TBL] [Abstract][Full Text] [Related]
29. Complementary phenol-enriched olive oil improves HDL characteristics in hypercholesterolemic subjects. A randomized, double-blind, crossover, controlled trial. The VOHF study.
Farràs M; Castañer O; Martín-Peláez S; Hernáez Á; Schröder H; Subirana I; Muñoz-Aguayo D; Gaixas S; Torre Rde L; Farré M; Rubió L; Díaz Ó; Fernández-Castillejo S; Solà R; Motilva MJ; Fitó M
Mol Nutr Food Res; 2015 Sep; 59(9):1758-70. PubMed ID: 26011257
[TBL] [Abstract][Full Text] [Related]
30. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
31. Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation.
Kaur HD; Bansal MP
Lipids Health Dis; 2009 Dec; 8():55. PubMed ID: 20015371
[TBL] [Abstract][Full Text] [Related]
32. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
Lee JH; Park JH; Lee SH; Kim JR; Cho KH
Int J Mol Med; 2010 Jun; 25(6):945-51. PubMed ID: 20428800
[TBL] [Abstract][Full Text] [Related]
33. A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial.
Barrat E; Zaïr Y; Ogier N; Housez B; Vergara C; Maudet C; Lescuyer JF; Bard JM; Carpentier YA; Cazaubiel M; Peltier SL
Int J Food Sci Nutr; 2013 Nov; 64(7):882-9. PubMed ID: 23815518
[TBL] [Abstract][Full Text] [Related]
34. Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study.
Preuss HG; Wallerstedt D; Talpur N; Tutuncuoglu SO; Echard B; Myers A; Bui M; Bagchi D
J Med; 2000; 31(5-6):227-46. PubMed ID: 11508317
[TBL] [Abstract][Full Text] [Related]
35. No Effect of Isolated Anthocyanins from Bilberry Fruit and Black Rice on LDL Cholesterol or other Biomarkers of Cardiovascular Disease in Adults with Elevated Cholesterol: A Randomized, Placebo-Controlled, Cross-Over Trial.
Aboufarrag H; Hollands WJ; Percival J; Philo M; Savva GM; Kroon PA
Mol Nutr Food Res; 2022 Nov; 66(21):e2101157. PubMed ID: 35385209
[TBL] [Abstract][Full Text] [Related]
36. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
37. Impaired Antiatherogenic Functions of High-density Lipoprotein in Patients with Ankylosing Spondylitis.
Gkolfinopoulou C; Stratikos E; Theofilatos D; Kardassis D; Voulgari PV; Drosos AA; Chroni A
J Rheumatol; 2015 Sep; 42(9):1652-60. PubMed ID: 26233507
[TBL] [Abstract][Full Text] [Related]
38. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
39. Purified human paraoxonase-1 interacts with plasma membrane lipid rafts and mediates cholesterol efflux from macrophages.
Berrougui H; Loued S; Khalil A
Free Radic Biol Med; 2012 Apr; 52(8):1372-81. PubMed ID: 22336243
[TBL] [Abstract][Full Text] [Related]
40. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
